Summary of Purpose
To test the hypothesis that the lack of efficacy of tirlazad mesylate demonstrated by RANTASS was secondary to inadequate dose, especially in females.Read More →
The following dates are available for this trial. Trial information last updated on 28 August 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Pharamacia-Upjohn, Inc., Kalamazoo, MI
Randomized, controlled, multicenter study involving 126 patients.
E. Clarke Haley, Jr, MD, Department of Neurology, Box 394, University of Virginia Health Sciences Center, Charlottesville, VA firstname.lastname@example.org